![PDF) Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis PDF) Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis](https://i1.rgstatic.net/publication/327227936_Medical_therapy_versus_transurethral_resection_of_the_prostate_TURP_for_the_treatment_of_symptomatic_benign_prostatic_enlargement_BPE_a_cost_minimisation_analysis/links/5b83e64c4585151fd1354955/largepreview.png)
PDF) Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis
![Should Combination Therapy be Standard for Benign Prostatic Hyperplasia? - Walter Bushnell Healthcare Foundation Should Combination Therapy be Standard for Benign Prostatic Hyperplasia? - Walter Bushnell Healthcare Foundation](https://wbhf.walterbushnell.com/images/Uro-Flash-2017/img1.png)
Should Combination Therapy be Standard for Benign Prostatic Hyperplasia? - Walter Bushnell Healthcare Foundation
![PDF) Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study PDF) Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study](https://i1.rgstatic.net/publication/347997811_Background_parenchymal_enhancement_on_contrast-enhanced_spectral_mammography_does_not_represent_an_influencing_factor_for_breast_cancer_A_preliminary_study/links/60173cd0a6fdcc071ba90d4d/largepreview.png)
PDF) Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
![Biomedicines | Free Full-Text | Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes Biomedicines | Free Full-Text | Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes](https://www.mdpi.com/biomedicines/biomedicines-10-02384/article_deploy/html/images/biomedicines-10-02384-g003.png)
Biomedicines | Free Full-Text | Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
Safety and Efficacy of Outpatient Surgical Procedures for the Treatment of Benign Prostatic Enlargement in New York State and Ca
![Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers | Breast Cancer Research | Full Text Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-015-0577-0/MediaObjects/13058_2015_577_Fig1_HTML.gif)
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers | Breast Cancer Research | Full Text
![JCM | Free Full-Text | Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies JCM | Free Full-Text | Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies](https://www.mdpi.com/jcm/jcm-12-01860/article_deploy/html/images/jcm-12-01860-g001.png)
JCM | Free Full-Text | Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies
![Frontiers | Development and validation a simple scoring system to identify malignant pericardial effusion Frontiers | Development and validation a simple scoring system to identify malignant pericardial effusion](https://www.frontiersin.org/files/Articles/1012664/fonc-12-1012664-HTML/image_m/fonc-12-1012664-g001.jpg)
Frontiers | Development and validation a simple scoring system to identify malignant pericardial effusion
Background Parenchymal Enhancement at Breast MR Imaging: Normal Patterns, Diagnostic Challenges, and Potential for False-Positiv
![Sensors | Free Full-Text | Dynamic Acoustic Unit Augmentation with BPE-Dropout for Low-Resource End-to-End Speech Recognition Sensors | Free Full-Text | Dynamic Acoustic Unit Augmentation with BPE-Dropout for Low-Resource End-to-End Speech Recognition](https://www.mdpi.com/sensors/sensors-21-03063/article_deploy/html/images/sensors-21-03063-g004.png)
Sensors | Free Full-Text | Dynamic Acoustic Unit Augmentation with BPE-Dropout for Low-Resource End-to-End Speech Recognition
![Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers | Breast Cancer Research | Full Text Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-015-0577-0/MediaObjects/13058_2015_577_Fig5_HTML.gif)
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers | Breast Cancer Research | Full Text
![Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management | Journal of Urology Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management | Journal of Urology](https://www.auajournals.org/cms/asset/d53add53-0b4d-4a20-85e0-53c88b4c5f6d/ju.0000000000002183f1.gif)
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management | Journal of Urology
![PDF) Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the PDF) Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the](https://i1.rgstatic.net/publication/304341219_Can_we_use_baseline_characteristics_to_assess_which_men_with_moderately_symptomatic_benign_prostatic_hyperplasia_at_risk_of_progression_will_benefit_from_treatment_A_post_hoc_analysis_of_data_from_the/links/5824acb608ae61258e428ba4/largepreview.png)